Literature DB >> 10795773

Reversible nefazodone-induced liver failure.

M A Eloubeidi1, J T Gaede, M W Swaim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10795773     DOI： 10.1023/a:1005558015787

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.487


× No keyword cloud information.
  8 in total

1.  Nefazodone--a novel antidepressant--may increase REM sleep.

Authors:  A L Sharpley; A E Walsh; P J Cowen
Journal:  Biol Psychiatry       Date:  1992-05-15       Impact factor: 13.382

Review 2.  The safety profile of nefazodone.

Authors:  D S Robinson; D L Roberts; J M Smith; J C Stringfellow; S B Kaplita; J A Seminara; R N Marcus
Journal:  J Clin Psychiatry       Date:  1996       Impact factor: 4.384

3.  Combined nitrofurantoin toxicity to liver and lung.

Authors:  H H Reinhart; E Reinhart; P Korlipara; R Peleman
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

4.  Nefazodone-induced liver failure: report of three cases.

Authors:  J Aranda-Michel; A Koehler; P A Bejarano; J E Poulos; B A Luxon; C M Khan; L C Ee; W F Balistreri; F L Weber
Journal:  Ann Intern Med       Date:  1999-02-16       Impact factor: 25.391

Review 5.  Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug.

Authors:  D P Taylor; R B Carter; A S Eison; U L Mullins; H L Smith; J R Torrente; R N Wright; F D Yocca
Journal:  J Clin Psychiatry       Date:  1995       Impact factor: 4.384

6.  Nitrofurantoin-induced hepatotoxicity mediated by CD8+ T cells.

Authors:  B D Kelly; M A Heneghan; F Bennani; C E Connolly; T A O'Gorman
Journal:  Am J Gastroenterol       Date:  1998-05       Impact factor: 10.864

7.  Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases.

Authors:  B H Stricker; A P Blok; F H Claas; G E Van Parys; V J Desmet
Journal:  Hepatology       Date:  1988 May-Jun       Impact factor: 17.425

8.  Single- and multiple-dose pharmacokinetics of nefazodone in patients with hepatic cirrhosis.

Authors:  R H Barbhaiya; U A Shukla; C S Natarajan; D A Behr; D S Greene; S M Sainati
Journal:  Clin Pharmacol Ther       Date:  1995-10       Impact factor: 6.875
  8 in total
  1 in total

Review 1.  Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.

Authors:  Catherine C Crone; Geoffrey M Gabriel
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.